Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. AMA Code Says Dec 2019 AMA Policies and Code of Medical Ethics’ Opinions Related to Human Genome Editing Abigail Scheper Gene editing reminds professionals and the public that this technology’s reach goes beyond treating somatic disease to germline consequences yet unknown. AMA J Ethics. 2019;21(12):E1056-1058. doi: 10.1001/amajethics.2019.1056. Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 1 Hasan Shanawani, MD, MPH Virtual Mentor. 2005;7(7):469-473. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507. Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 2 Kathleen Nathan Lowe, MSW, ACSW, CMSW Virtual Mentor. 2005;7(7):473-475. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507. Case and Commentary Dec 2016 Neuroethics and Disorders of Consciousness: Discerning Brain States in Clinical Practice and Research Joseph J. Fins, MD Which distinctions between minimally conscious states and vegetative states should clinicians consider? AMA J Ethics. 2016;18(12):1182-1191. doi: 10.1001/journalofethics.2016.18.12.ecas2-1612. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408. Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021;E18-25. doi: 10.1001/amajethics.2021.18. Case and Commentary Feb 2021 通过避免判断主义和情境化护理来促进卫生公平性 Saul J. Weiner (医学博士) AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
AMA Code Says Dec 2019 AMA Policies and Code of Medical Ethics’ Opinions Related to Human Genome Editing Abigail Scheper Gene editing reminds professionals and the public that this technology’s reach goes beyond treating somatic disease to germline consequences yet unknown. AMA J Ethics. 2019;21(12):E1056-1058. doi: 10.1001/amajethics.2019.1056.
Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 1 Hasan Shanawani, MD, MPH Virtual Mentor. 2005;7(7):469-473. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507.
Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 2 Kathleen Nathan Lowe, MSW, ACSW, CMSW Virtual Mentor. 2005;7(7):473-475. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507.
Case and Commentary Dec 2016 Neuroethics and Disorders of Consciousness: Discerning Brain States in Clinical Practice and Research Joseph J. Fins, MD Which distinctions between minimally conscious states and vegetative states should clinicians consider? AMA J Ethics. 2016;18(12):1182-1191. doi: 10.1001/journalofethics.2016.18.12.ecas2-1612.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408.
Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021;E18-25. doi: 10.1001/amajethics.2021.18.
Case and Commentary Feb 2021 通过避免判断主义和情境化护理来促进卫生公平性 Saul J. Weiner (医学博士) AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91.